OCTOBER 13-14, 2021
Get in touch with Corporates, Manufacturers and investors
Organised by BadenCampus together with its partners from the Life Science Accelerator Baden-Württemberg, SEMIA (member of the Quest for change network) and the University of Basel, the ‘Trinational HealthTech Days #2’ business event aims to connect innovative startups and the ecosystems from France, Germany and
- a better understanding of the opportunities for startups to gain access to clinics in order to validate and test their products and services.
- a better understanding of how corporates work together with startups to improve their chances of success.
- the opportunity to network with international startups and connect with funds, VCs and corporate investors.
Take a look at last year's page
PROGRAM
13th October - Day 1
Market access strategy for health products and country particularities
OPENING PLENARY SESSIONS: 14:00 – 14:15
14:00 – 14:15
Opening remarks
Speakers:
Dr. Guillaume Vetter-Genoud, Head of deeptech/healthcare, SEMIA
Maarten van Winckel, Startup Community & Initiatives at University of Basel
Bodo Brückner, Startup Advisor; Coordinator Lifescience Accelerator Baden-Wuerttemberg
Markus Bühler, Coordinator Lifescience Accelerator Baden-Wuerttemberg
THEMATIC WORKSHOP SESSIONS: 14:15 – 15:15
14:15 – 15:15
From the 1st experimentations until the clinical trials.
This session will shed some light on how startup teams can get access to hospitals. To this end the speakers will present different approaches and strategies ranging from consultancy services to whole clinical departments including patient, nurses and doctors interacting with teams.
Moderator: Bodo Brückner
Speakers:
Mirjam Schleske, Organisational Management INSPIRE Living Lab
Dr. Christian Haverkamp, Acting Director, "Institut für Digitalisierung in der Medizin" at Uniklinik Freiburg
Matis Ringdal, CEO at Pixacare
Olivier Terenzi, Clinical research project manager at OMEOS
14:15 – 15:15
This session will, in a very open manner, address topics relevant for start-ups wanting to collaborate with corporates / big pharma. What do you need to consider to maximize your chances for collaboration and when is the best time in your journey to think about this endeavor, are just a few of the questions that will be addressed during this session.‘
Moderator: Maarten Van Winckel
GENERAL TALK: 15:25 – 16:25
15:25 – 16:25
Successful access and cooperation
How does the successful acquisition of a significant investment work, what are the main hurdles after the first access in clinics and how can corporates and startups work together to accelerate this journey?
Speakers:
Dr. Michael Luettgen, Liason Manager at German EIT Health GmbH
Heiko Bähr, Senior Consultant at Medidee Services
Dipl.-Ing. Catherine Schreiber, deputy CEO & COO at ADVITOS GmbH
CLOSING REMARKS: 16:25 – 16:40
16:25 – 16:40
Closing remarks
14th October - Day 2
One-on-One meetings of startups and investors/corporates
INSTRUCTIONS: 14:00 – 14:15
14:00 – 14:15
Opening & Instructions
ONE-ON-ONE SESSIONS: 14:15 – 17:00
14:15 – 17:00
One-on-One sessions
ORGANIZATION COMMITTEE
Bodo Brückner
Startup Advisor; Coordinator Lifescience Accelerator Baden-Wuerttemberg
Markus Buehler
Coordinator Lifescience Accelerator Baden-Wuerttemberg
Amélie Gallego
Head of Communication, SEMIA
Dr. Yves Gendrault
Public research projet manager at SEMIA
Dr. Roman Neidl
PhD, MSc - Healthcare Business manager, SEMIA
Dr. Thomas Scheuerle
Managing Director, BadenCampus
Dr. Katerina Tsouroula
PhD, MSc - Digital health Business manager, SEMIA
Maarten Van Winckel
Startup Community & Initiatives, University of Basel
Dr. Guillaume Vetter-Genoud
PhD, MBA - Head of deeptech / healthcare, SEMIA
Linda Wistup
Room, community and event / trainer, BadenCampus
Corporates
Venture capital
Business Angels
KIC
